Colon specific delivery of budesonide based on triple coated pellets: In vitro/in vivo evaluation

Acta Pharmaceutica

Volumn 62, Issue 3, 2012, Pages 341-356

  Varshosaz, Jaleh ^a   Emami, Jaber ^a   Tavakoli, Naser ^a   Minaiyan, Mohsen ^a   Rahmani, Nakisa ^a   Dorkoosh, Farid ^b   Mahzouni, Parvin ^c  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Budesonide; Colon delivery; Eudragit E; HPMC; HPMC AS; Three layered pellets

Indexed keywords

BUDESONIDE; CITRIC ACID; EUDRAGIT; HYDROXYPROPYLMETHYLCELLULOSE; MICROCRYSTALLINE CELLULOSE; TRINITROBENZENESULFONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY MASS; COLITIS; COLON; CONTROLLED STUDY; DRUG PELLET; DRUG RELEASE; HISTOPATHOLOGY; MALE; NONHUMAN; PELLET EXTRUSION; RAT;

EID: 84876592174     PISSN: 13300075     EISSN: 18469558     Source Type: Journal    
DOI: 10.2478/v10007-012-0025-y     Document Type: Article

References (20)

1. D. C. Baumgart, Treatment of inflammatory bowel disease: A review of medical therapy, World J. Gastroenterol. 21 (2008) 354-377; DOI: 10.3748/wjg.14.354. (Pubitemid 351320845)
2. U. Klotz and M. Schwab, Topical delivery of therapeutic agents in the treatment of inflammatory bowel disease, Adv. Drug Deliv. Rev. 57 (2005) 267-279; DOI: 10.1016/j.addr.2006.09.011. (Pubitemid 39536102)
3. M. Jiménez and A. S. Peña, Budesonide for ulcerative colitis, Rev. Esp. Enferm. Dig. 98 (2006) 362-373; DOI: 1130-0108/2006/98/5/362- 373. (Pubitemid 47343533)
4. K. Dilger, M. Alberer, A. Busch, A. Enninger, R. Behrens, S. Koletzko, M. Stern, C. Beckmann and C. H. Gleiter, Pharmacokinetics and pharmacodynamic action of budesonide in children with Crohn's disease, Aliment. Pharmacol. Ther. 23 (2006) 387-395; DOI: 10.1111/j.1365-2036.2006. 02771.x.
5. J. Seidegård, L. Nyberg and O. Borgå, Presystemic elimination of budesonide in man when administered locally at different levels in the gut, with and without local inhibition by ketoconazole, Eur. J. Pharm. Sci. 15 (2008) 264-70; DOI: 10.1016/j.ejps.2008.07.005.
6. L. F. Asghar and S. Chandran, Multiparticulate formulation approach to colon specific drug delivery: current perspectives, J. Pharm. Pharm. Sci. 9 (2006) 327-338. (Pubitemid 46614339)
7. Y. Krishnamachari, P. Madan and S. Lin, Development of pH-and time-dependent oral microparticles to optimize budesonide delivery to ileum and colon, Int. J. Pharm. 29 (2007) 238-47; DOI: 10.1016/j.ijpharm.2007.02.015. (Pubitemid 46777247)
8. A. Makhlof, Y. Tozuka and H. Takeuchi, pH-Sensitive nanospheres for colon-specific drug delivery in experimentally induced colitis rat model, Eur. J. Pharm. Biopharm. 72 (2009) 1-8; DOI: 10.1016/j.ejpb.2008.12.013.
9. United States Pharmacopoeia 32, National Formulary 29, USP Convention, Rockville 2002.
10. J. Varshosaz, J. Emami, N. Tavakoli, A. Fassihi, M. Minaiyan, F. Ahmadi and F. Dorkoosh, Synthesis and evaluation of dextran-budesonide conjugates as colon specific prodrugs for treatment of ulcerative colitis, Int. J. Pharm. 365 (2009) 69-76; DOI: 10.1016/j.ijpharm.2008.08.034.
11. J. Ding, X. Wang, T. Zhang, Q. Li and M. Luo, Optimization of RP-HPLC analysis of low molecular weight organic acids in soil, J. Liq. Chrom. Rel. Tech. 29 (2006) 99-111; DOI: 10.1080/10826070500363050. (Pubitemid 41831767)
12. T. Higuchi, Mechanism of sustained-action medication, J. Pharm. Sci. 52 (1963) 1145-1149; DOI: 10.1002/jps. 2600521210.
13. R. W. Korsmeyer, R. Gurny, E. Doelker, P. Buri and N. A. Peppas, Mechanisms of solute release from porous hydrophilic polymers, Int. J. Pharm. 15 (1983) 25-35; DOI: 10.1016/0378-5173(83) 90064-9. (Pubitemid 13092121)
14. N. A. Peppas, Analysis of Fickian and non-Fickian drug release from polymers, Pharm. Acta Helv. 60 (1985) 110-111.
15. P. Costa and J. M. Sonsa Lobo, Modelling and comparison of dissolution profiles, Eur. J. Pharm. Sci. 13 (2001) 123-133; DOI: 10.1016/S0928-0987(01) 00095-1. (Pubitemid 32288781)
16. G. P. Morris, P. L. Beck, M. S. Herridge, W. T. Depew, M. R. Szewczuk and J. L. Wallace, Hapten-induced model of colonic inflammation and ulceration in the rat colon, Gastroenterology 96 (1989) 795-803. (Pubitemid 19057602)
17. S. Choudhary, A. Keshavarzian, S. Yong, M. Wade, S. Bocckino, B. J. Day and A. Banan, Novel antioxidants zolimid and AEOL11201 ameliorate colitis in rats, Dig. Dis. Sci. 46 (2001) 2222-2230; DOI: 10.1023/A: 1011975218006. (Pubitemid 32955236)
18. S. Y. Zhou, Q. B. Mei, L. Liu, X. Guo, B. S. Qiu, D. H. Zhao and C. H. Cho, Delivery of glucocorticoid conjugates in rat gastrointestinal tract and its treatment for ulcerative colitis, Acta Pharmacol. Sin. 22 (2001) 761-764. (Pubitemid 32772424)
19. J. L. Wallace and C. M. Keenan, An orally active inhibitor of leukotriene synthesis accelerates healing in a rat model of colitis, Am. J. Physiol. 258 (1990) 527-534.
20. C. B. Appleyard and J. L. Wallace, Reactivation of hapten-induced colitis and its prevention by anti-inflammatory drugs, Am. J. Physiol. 269 (1995) 119-125.